Hypnosis in Autonomic Function
NCT00061009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2008-03-04
Summary
This study will investigate the relationship between susceptibility to hypnosis and regulation of the autonomic nervous system (nerves that control involuntary body functions, such as heart rate and sweating).
Hypnosis is a state of mind in which the individual is highly focused, relatively unaware of his or her surroundings, and possibly more able to accept and use therapeutic suggestions. People vary in their responsiveness, or susceptibility, while in hypnosis. People with certain conditions, such as chronic fatigue syndrome (CFS), chronic pain, posttraumatic stress disorder (PTSD), and generalized anxiety disorder (GAD) have altered hypnotic susceptibility. Patients with chronic orthostatic intolerance (COI) often have symptoms similar to those of individuals with CFS, chronic pain, PTSD, and GAD, and this study will examine how patients with COI respond to hypnosis as compared with healthy normal volunteers. COI is a group of disorders characterized by intolerance to prolonged standing. Among them are neurocardiogenic syncope (NCS), in which patients have recurrent episodes of sudden loss of consciousness, and postural tachycardia syndrome (POTS), in which patients have a sustained increase in heart rate after standing.
In addition to the comparison of COI and normal volunteer responses to hypnosis, the study will examine how hypnotic susceptibility is related to the ability to control autonomic functions such as blood pressure, heart rate, and sweating. The autonomic nervous system is activated when the body is stressed, not only from physical stimuli such as cold temperature, but also from mental stimuli, such as seeing a rattlesnake up close. Hypnosis may, therefore, be a useful tool to understand how the mind controls the autonomic nervous system.
Healthy normal volunteers and patients with NCS or POTS who are 18 years of age or older may be eligible for this two-part study. In part 1, participants complete a questionnaire and are then tested for hypnotic susceptibility. For this test, a professionally trained physician guides the subject through a procedure to achieve a hypnotic state. The subject is asked to perform several simple tasks and is then guided back to a normal state of being. In part 2, the subject undergoes hypnosis again, during which the physician offers various suggestions while monitoring activity of the subject's autonomic nervous system. The subject is connected to various sensors that continuously monitor blood pressure, heart rate, blood flow, sweat response, skin electrical conduction, and brain wave activity. An intravenous catheter is inserted into an arm vein to collect blood samples. At the end, the subject is guided back to a normal state of being.
The hypnosis session in part 1 is videotaped in order to: 1) permit review by a scientist who is unaware of the subject's condition and whose judgment will not, therefore, be biased; and 2) have a record of the experimental data. Only qualified investigators will view the videotape.
Conditions
- Vasovagal Syncope
- Postural Tachycardia Syndrome
- Hypnosis
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-05-31
- Completion
- 2006-01-31
Countries
- United States
Study Locations
More Related Trials
-
Cardiovascular and Cerebrovascular Control in Healthy Subjects
NCT05706532 ·Status: RECRUITING
-
Autonomic Nervous System and Nitric Oxide Interactions
NCT01137253 ·Status: COMPLETED ·Phase: PHASE1
-
Anxiety and Cardiovascular Autonomic Control
NCT00005471 ·Status: COMPLETED
-
Transplanted-like Heart in Critical Ill Patients
NCT01930669 ·Status: COMPLETED ·Phase: NA
-
Mental Stress, Autonomic Function, and Heart Disease
NCT00005524 ·Status: COMPLETED
-
The Effect of Autonomic Function on Coronary Vasomotion
NCT01877993 ·Status: COMPLETED
-
Study of Norepinephrine Levels and Sympathetic Nervous System Activity
NCT00001329 ·Status: COMPLETED
-
Autonomic Determinants of POTS - Pilot 2
NCT04140721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Prevalence of Coronary Spasm in Hypertensive Patients Treated With Antihypertensive Medication
NCT01882790 ·Status: COMPLETED
-
Influence of the Autonomic Nervous System in Response to Exercise in Hypertensive Individuals
NCT04371757 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial for the Prevention of Vasovagal Syncope
NCT00118482 ·Status: COMPLETED ·Phase: PHASE4
-
Nitric Oxide and the Autonomic Nervous System
NCT00178919 ·Status: COMPLETED ·Phase: NA
-
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
NCT02123056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Autonomic Determinants of POTS - Pilot1
NCT04050410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Relation Between Vasovagal Tendency and Smoking Among University Students
NCT02949804 ·Status: COMPLETED
-
Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia
NCT05256069 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients
NCT02219451 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia
NCT05021627 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hostility Reduction Program to Improve Autonomic Regulation of the Heart
NCT00365196 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope
NCT00004479 ·Status: COMPLETED ·Phase: NA
-
Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System
NCT03109795 ·Status: TERMINATED ·Phase: PHASE4
-
Sympathetic Nervous System Modulation in Hypertension
NCT00491387 ·Status: TERMINATED ·Phase: PHASE4
-
The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation
NCT02315313 ·Status: UNKNOWN
-
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
NCT00555880 ·Status: COMPLETED ·Phase: PHASE4